Nowadays, the incidence rate of lung cancer is still high, and the five-year survival rate of patients is low. Immunotherapy is a hot spot in the field of lung cancer. There are more and more clinical problems that need to be discussed and solved. The Chengdu High tech Medical Association invites outstanding experts from both inside and outside Sichuan Province to jointly discuss new developments and experience sharing in the diagnosis and treatment of lung cancer, better summarize experiences, improve treatment levels, build academic platforms, and benefit more medical personnel and patients. The "Chest Cancer Academic Forum for Middle and Young People" was successfully held online on March 30, 2024, hosted by the Chengdu High tech Medical Association. The conference invited well-known experts in the field of lung cancer in the southwest region to give lectures, focusing on topics such as new developments in lung cancer immunotherapy. A platform for exchange and learning was built for colleagues through academic lectures, thematic discussions, and other forms.